Avior Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Avior Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6	Closed	-$1K	–	1173
2021 Q1	$1K	Hold	6	–	–	﹤0.01%	992
2020 Q4	$0	Hold	6	–	–	﹤0.01%	1116
2020 Q3	$0	Hold	6	–	–	﹤0.01%	1051
2020 Q2	$0	Hold	6	–	–	﹤0.01%	1012
2020 Q1	$0	Hold	6	–	–	﹤0.01%	929
2019 Q4	$0	Hold	6	–	–	﹤0.01%	902
2019 Q3	$0	Buy	+6	New	+$911	﹤0.01%	903
2017 Q1	–	Sell	-100	Closed	-$11K	–	541
2016 Q4	$11K	Buy	+100	New	+$12K	﹤0.01%	327

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Avior Wealth Management's GWPH Position: Q2 2021 in Review

Avior Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 6 shares — an estimated $1K sold.

Avior Wealth Management first reported a position in GWPH in Q4 2016 and held it in 8 quarters. The position peaked at $11K in Q4 2016. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Avior Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Avior Wealth Management sold 6 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1K.
Avior Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 8 quarters.
Avior Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11K in Q4 2016.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Avior Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2021.